Here's a repeat of a post in August
As described in May’s Investor Presentation (Slide 12)
TPM solubilises propofol without excipients that can be allergenic or promote bacterial growth
http://www.phosphagenics.com/wp-content/uploads/2017/05/POH-Investor-Presentation-2-May-17.pdf
As described in 2015 presentation (Slide 8)
TPM enhances solubility and stability
https://hotcopper.com.au/threads/an...ion-australian-roadshow.2632335/#.WZzuOigjGUk
Here’s a link to an earlier post on Propofol recall due to bacterial contamination
https://hotcopper.com.au/threads/propofol-recall.2237936/?post_id=13329072#.WZzyfSgjGUk
And another on the propofol market…
https://hotcopper.com.au/threads/propofol-recall.2237936/page-8?post_id=18318854#.WZzyvSgjGUk
Ann: Phosphagenics Update on TPM/Propofol Development Program, page-7
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $540 | 270K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 13918600 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41116983 | 27 |
View Market Depth
| Last trade - 10.35am 05/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |